Updated Jul 16, 2026
Bertrand John D. has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Bertrand John D. is identified in the SEC filing as a director of OraSure Technologies, Inc. as of May 15, 2026. OraSure Technologies, Inc. is a medical diagnostics company known for oral-fluid-based tests (e.g., OraQuick). The SEC filing confirms his board membership, but there is no additional biographical detail publicly available within the provided SEC context to establish his education, career history, or other qualifications. Based on the available information, he serves as a non-executive director at OraSure Technologies.
| Role | Director |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | OSUR | ORASURE TECHNOLOGIES INC | A — Grant or award | 46.1K | $0.00 | |
| 2026-05-15 | OSUR | ORASURE TECHNOLOGIES INC | A — Grant or award | 33.7K | $0.00 |
Bertrand John D. is identified in the SEC filing as a director of OraSure Technologies, Inc. as of May 15, 2026. OraSure Technologies, Inc. is a medical diagnostics company known for oral-fluid-based tests (e.g., OraQuick). The SEC filing confirms his board membership, but there is no additional biographical detail publicly available within the provided SEC context to establish…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bertrand John D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.